Since the beginning of the HIV-1 pandemic more than 35.4 million (25.0-49.9 million) people have died of AIDS-related illnesses 1 . South Africa experiences the largest HIV-1 epidemic with 7.2 million infected individuals 2 . The first HIV-1 cases in South Africa were reported in 1983 and the infections were confined to men who have sex with men (MSM) and bi-sexual risk groups 3 . The viral sequences between 1984 and 1990 were characterized as HIV-1 subtypes B and D [4] [5] [6] . The spread of HIV-1 subtype C in the heterosexual population in South Africa has been on the increase since it was first identified in the late 1980s 7 .
There is a total of 182 short fragment HIV-1 subtype B sequences from South Africa available in the Los Alamos HIV database (http://www.hiv.lanl.gov), accessed in September 2018. The majority of these short fragment sequences belong to the envelope (env) coding region and the gag-pol region. Out of these, only five subtype B near full-length genome sequences from South Africa have been published: R84 (FJ647145) 8 , TV016 (KJ948656) 9 , TV047 (KJ948657) 9 , TV1057 (KJ948660) 9 , and 03ZAPS045MB2 (DQ396398)10 10 . Four of these sequences were characterized in our laboratory. Patient R84 was a MSM sampled in 1985 8 , TV016 was a heterosexual male sampled in 1988, TV047 was a heterosexual male sampled in 2000 and TV1057 was an MSM sampled in 2002 9 . Wilkinson et al. 9 described these sequences, while Rousseau et al. 10 described patient sequence 03ZAPS045MB2, a female sampled in 2003. Thus, there are limited information available for HIV-1 subtype B near full-length sequences from the early epidemic in South Africa. In Africa, there is only one published near full-length HIV-1 subtype B sequence OYI 397 from Gabon, described by Huet et al.
11
. Patient sequence OYI_397 was sampled in 1988 and the risk factor, gender and patient ethnicity were not recorded 11 .
Recombinant analyses.
A representation of the unique recombinant form between subtypes B and D of R605 is illustrated in Fig. 2 . The following breakpoints were observed from the jpHMM analyses: gag -pol (862-3918 bp HXB2) subtype B, pol -vif (3918-5974 bp HXB2) subtype D and vpu -env (5974-9187 bp HXB2) subtype B. In order to validate the recombinant breakpoints, ML phylogenetic trees were inferred for each fragment.
Discussion
In 1982 the first two HIV-1 patients were reported in South Africa in MSM patients. Both had contacts in the USA before developing AIDS 3 . In South Africa, two independent epidemics have been described 7 . The first was initially spread by MSM. This was later identified as HIV-1 subtype B and D [4] [5] [6] . The second epidemic started to expand in the heterosexual population as far back as early 1988, with seroprevalence data in blood donor populations from different race groups that showed a characteristic pattern. These independent epidemics are consistent respectively to global epidemiological patterns 12 . In addition, human migration is a major process that shaped the origin and dissemination of HIV-1 13 . Data generated by Wilkinson et al. 14 indicate that in South Africa the bulk of viral introductions occurred during a period of socio-political change in the country (1980-2000) 14 . Based on our current knowledge South Africa experienced multiple introductions of HIV-1 from neighbouring countries towards the move to full independence in the 1990s, after the end of Rhodesian bush war 15 . The results generated from this study further strengthen the hypothesis of the presence of HIV-1 subtype B and HIV-1 subtype D amongst the MSM risk group at the beginning of the epidemic in the country. This may also explain the HIV-1 subtype BD URF detected and sequenced from the PBMC of patient R605.
In 2014, an unusual high HIV-1 subtype diversity was described in Cape Town 16 . This suggests that international tourism and MSM migration into the country, seeking constitution protection, might play a vital role to the MSM network in Cape Town 16 . Furthermore, there has been an increase in the number of subtype B cases spread through heterosexual and mother-to-child transmission. In this study, five new near full-length HIV-1 sequences were characterized: four subtype B's (R68, R459, R526 and R1296) and one unique subtype B and D recombinant form (R605). The near full-length subtype B sequences included in this study were isolated from both MSM and heterosexual individuals. Patient R84 sampled in 1985 (GenBank FJ647145) is the only subtype B near full-length sequence which has been characterized from the early epidemic in South Africa 8 . This subtype B isolate, along with 5 subtype D viruses, were characterized in three separate studies, represents the only near full-length sequences of the early MSM HIV-1 epidemic within South Africa [4] [5] [6] . Three subtype B sequences have been described from the later epidemic: TV016 sampled in 1998 (GenBank KJ948656) 9 , TV047 sampled in 2000 www.nature.com/scientificreports www.nature.com/scientificreports/ (GenBank KJ948657) 9 and TV1057 sampled in 2002 (GenBank KJ48660) 9 . In Gabon, OYI_397 sampled in 1988 represents the only other HIV-1 subtype B near full-length sequence published from Africa www.nature.com/scientificreports www.nature.com/scientificreports/ world and only 10 (12.04%) of these sequences were not from Africa. Loxton et al. 4 , and Jacobs et al. 5 , described five HIV-1 subtype D viruses from South Africa. Limited focus has been placed on this HIV-1 subtype D in this country. In 1997, HIV-1 subtype D was identified in a male MSM and one heterosexual patient through partial gag analysis 17 . Bredell et al. 18 conducted a study where they identified a HIV-1 subtype C and D recombinant in a heterosexual through partial sequencing of gag and env gene. Furthermore, in the same study, they also identified HIV-1 subtype D in a male heterosexual through partial sequencing of the gag gene. There are currently 83 near full-length HIV-1 subtype D sequences in the Los Alamos Database, of which only ten were not from Africa. Before 1990 there was eight near-full-length subtype D sequences described. Four of these sequences, R2 (1984), R214 (1985) , R286 (1985) and R482 (1986), were from South Africa 4 . The other four sequences were from the DRC: NDK (1983) 19 , ELI (1983) 20 , 84ZR085 (1984) 21 and CDC Z2 (1985) 22 . In this study, we identified an HIV-1 subtype BD Unique Recombinant Form (URF) from a patient sample obtained in 1985 during the start of the epidemic in South Africa. To the best of our knowledge, R605 is the first URF_BD described in the world. In South Africa, previous studies have identified the presence of URFs. In 2014, Jacobs and co-workers described the emergence of a possible URF of HIV-1 subtype B and C in South Africa 23 . In addition, the presence of recombinants AD (TV101) and AC (TV218) were also described. TV101 is the second AD recombinant described in 2015 and is closely related to AF457082 from Kenya 24 . The first AD recombinant characterized were from a South African patient that was infected via heterosexual contact in Kenya. Recombinant AC (TV218) was sampled from a 25-year-old female in Durban 9 . Two AC recombinant forms were also described by Rousseau et al. 10 and Papathanasopoulos et al.
25
. The breakpoints (recombination events) in all four of the AC recombinant fragments differ and thus each one represents URFs. In addition, previous studies have described the presence of unique inter-subtype recombinants such as BC, BF, and AC in both the MSM and heterosexual populations 16, 23, 25 .
Conclusion
With the advancement of molecular techniques and the availability of stored samples, we managed to characterize an HIV-1 recombinant sequence, sampled in 1985 in South Africa. Phylogenetic inference of five newly sequenced HIV-1 strains, identified subtypes B and the novel BD recombinant. Characterization of HIV-1 sequences during the early years were often based on short sub genomic regions. This most likely limited the identification of recombinant viral strains. Only near full-length genome analyses of HIV-1 can enable us to make accurate assumptions on viral recombination and pure subtypes. It is necessary to continue monitoring the evolution and spread of HIV-1 as understanding HIV-1 diversity can help us understand specific transmission patterns and help us understand how the virus continues to spread in South Africa and worldwide. PBMC cultures. PBMC cultures were performed as previously described 26 . Briefly, lymphocytes were separated from the buffy layer on a ficoll gradient and cultured at 37 °C in an atmosphere of 5% CO 2 . The RPMI-1640 medium was supplemented with 20% fetal calf serum, 0.2% Na(HCO 3 ) 2 , 2% L-glutamine, antibiotics, and 10-20% Interleukin 2. These PBMCs were co-cultured using umbilical cord lymphocytes that were stimulated with Phytohaemagglutinin for 3 days and treated with Polybrene for 30 minutes before co-cultivation. The medium was replaced every 2 to 3 days and the cell cultures were examined daily for cytopathic effect (CPE).
Reverse transcriptase assay. The reverse transcriptase (RT) assays were performed as previously described 27 . Briefly, RT activities were assayed in cell-free supernatants of control and infected PBMC cultures. Aliquots of 5 to 20 ml of supernatant fluid were clarified by centrifugation at 10 000 g for 10 minutes, thereafter pelleted at 100 000 g for 50 minutes. The pellets were re-suspended in 60 µl of lysis buffer (10 Mm Tris, 0.2% Triton X-100, 1 mM EDTA, 5 mM dithiothreitol, and 60 mM KCI, pH 7.3). The assays were performed in duplicate on 30 µl amounts of pellet lysate. The template used was 0.01 mg/ml poly(rA) oligo(dT) (Pharmacia, Sweden) in 5 mM MgCl 2 , 2.4 mM Dithiothreitol, 60 mM KCL and 0.0034 mM methyl [H]thymidine-5′ -triphosphate (48 CI/ mMole) (Amersham, England).
Nucleic acid extraction. High molecular weight DNA was extracted from the HIV-1 positive cultures and PBMCs using conventional phenol-chloroform extraction methods and stored at 4 °C.
PCR amplification. The NFLG amplification protocol was adapted from Grossman et al. 28 . Briefly, two overlapping fragments were amplified using the high fidelity KAPA HiFi HotStart ReadyMix (2X) (KAPA Biosystems, USA). The first fragment (F1) ranges from gag to vpu, position 0776-6231, approximately 5.5 kilobases [kb] in length, relative to HXB2 (Fig. 3) . First round PCR was performed with the primer pair 0682F (5′-TCTCTCGACGCAGGACTCGGCTTGCTG-3′) and 6352R (5′-GGTACCCCATAATAGACTG TRACCCACAA-3′), followed by second round nested primer pair with 0776F (5′-CTAGAAGGAGAGAGAG ATGGGTGCGAG-3′) and 6231R (5′-CTCTCATTGCCACTGTCTTCTGCTC-3′) 28 . The PCR cycling conditions were as follows: Initial denaturation of 95 °C for 5 minutes, followed by 30 cycles of 98 °C for 20 seconds, 65 °C for 15 seconds and 72 °C for 3 minutes and a final extension at 72 °C for 5 minutes. The second www.nature.com/scientificreports www.nature.com/scientificreports/ fragment (F2) starts from the vif to the 3′LTR, 5861 to 9555, approximately 3.7 kb in length, relative to HXB2. The F2 PCR was performed with first round primers 5550F (5′-AGARGAYAGATGGAACAAGCCCCAG-3′) and 9555R (5′-TCTACCTAGAGAGACCCAGTACA-3′), followed by second round nested PCR with primers 5831F (5′-TGGAAGCATCCRGGAAGTCAGCCT-3′) and 0440R (5′-CCAGAGCTCACCTAGCACCA TCCAAAGGTCAGTGGG-3′). The PCR cycling conditions were as follows: Initial denaturation of 95 °C for 5 minutes, followed by 30 cycles of 98 °C for 20 seconds, 65 °C for 15 seconds and 72 °C for 2 minutes and final extension at 72 °C for 5 minutes. Each PCR reaction contained 25 µl of KAPA HiFi HotStart ReadyMix (2X), 1.5 µl of each primer (10 μm), 5 µl of template DNA at a concentration of 20 ng/µl and 17 µl of nuclease-free water to a final volume of 50 µl.
PCR purification. PCR products were purified using the direct QIAquick PCR purification kit. The QIAquick gel extraction kit was used where multiple bands were visible on the agarose gel (Qiagen, Germany). Purification steps were performed according to the manufacturer's instructions. Sequence quality control. The nucleotide sequences were verified for stop codons, insertion and deletions using an online quality control program on the HIV LANL database (https://www.hiv.lanl.gov/content/sequence/ QC/index.htm). Each patient's sequences were named according to the 2-letter country code.year.name, for example ZA.85.R1296. HIV BLAST was used to find sequences similar to our sequences https://www.hiv.lanl. gov/content/sequence/BASIC_BLAST/basic_blast.html. Thereafter, patient's HIV sequences were preliminary characterized and subtyped using the jumping profile Hidden Markov Model (jpHMM) (http://jphmm.gobics. de/) 29 Multiple sequence alignments were done with MAFFT version 7.388 31, 32 , as implemented in Geneious version 11.1.5 (https://www.geneious.com). This multiple alignment was further refined by using the HMM option in HIVAlign (https://www.hiv.lanl.gov/content/sequence/VIRALIGN/viralign.html) and manually checked. The best fitting evolutionary model of nucleotide substitution was estimated in Mega version 6.06 33 , using 24 different nucleotide substitution models. The model with the lowest Bayesian Information Criterion (BIC) score was used for further analysis. Subsequently the Maximum Likelihood tree was inferred with the general time reversible (GTR) model of nucleotide substitution 34 , using a discrete Gamma distribution (+G) with five rate categories and by assuming that a certain fraction of sites are evolutionarily invariable (+I) 35 . To test the reliability of the inferred ML tree, we used bootstrap analysis with a total of 100 replicates.
Sequencing.
Recombination analyses. Based on the breakpoints identified with the jpHMM online tool, ML tree topologies were inferred for each of the recombinant fragments of R605. Each fragment was aligned with the HIV-1 subtype reference alignment in MAFFT 7.388 33, 34 , as implemented in Geneious 11.1.5 (https://www.geneious. com). ML phylogenetyic trees were inferred with MEGA 6.06 as described before.
GenBank. The sequences analysed from the study have been submitted to Genbank and are available under the following accession number: MH234639, MH234640, MH234641, MH234642 and MH234643.
